2nd Global
Cell & Gene Therapy Summit

July 07-09, 2025 (Hybrid) | Orlando, FL

Venue: Holiday Inn & Suites - Hotel

// CGT-SUMMIT 2025

Experts speaking

Howard Federoff
Howard Federoff

Chief Medical Officer & Co-Founder
Kenai Therapeutics, FL

Sebastien Ribault
Sebastien Ribault

Chief Commercial Officer
OXB, UK

Courtney Silverthorn
Courtney Silverthorn

Vice President, Strategic Alliances and Innovation
FNIH, MD

Arun Upadhyay
Arun Upadhyay

CSO & Head of Research & Development
Ocugen, PA

Nathalie Cartier-Lacave
Nathalie Cartier-Lacave

VP Neurobiology, CNS Sector Lead
Askbio, France

Alicia D. Henn
Alicia D. Henn

CSO
BioSpherix, Ltd., NY

Daniel Gibson
Daniel Gibson

Head of collaborations
Cell and Gene Therapy Catapult, UK

Jonathan Yuin-Han LOH
Jonathan Yuin-Han LOH

Deputy Executive Director
A*STAR Institute of Molecular and
Cell Biology, Singapore

// ABOUT SUMMIT

Cell & Gene Therapy Summit- 2025

We cordially invite you to The Global Cell & Gene Therapy Summit, which will be held in Orlando, FL, from July 07 to 09, 2025. Professionals and researchers are requested to take part as delegate, sponsor, or exhibitor. The three-day conference aims to bring together the global audience to discuss and exchange ideas on the origin, development, clinical applications and translation science of cell & gene therapy.

The inclusion of talks, poster presentation, workshops, discussions and networking events over the three days indicates a comprehensive program design to engage participants of various interactive formats. It allows the attendees to learn from experts, showcase their own research through posters, participate in workshops to gain practical insights, engage in discussions to share perspectives, and connect with professional researchers from diverse backgrounds.

By fostering such an environment, The Global Cell & Gene Therapy Summit, provides an excellent platform for researchers, clinicians, industry professionals, and other stakeholders to stay up to date with the latest advancements in the field of cell & gene therapy. It also facilitates collaboration and the exchange of knowledge, which is crucial for accelerating the translation of scientific discoveries into potential clinical applications.

Comprehensively, the event plays a vital role in bridging the gap between academia and the industry by fostering collaboration, promoting innovation, and facilitating the dissemination of knowledge in the field of cell & gene therapy.

// CGT-2025

Key Highlights

Icon

Collaboration at the Core

CGT-2025 is dedicated to bridging the gap between academia and industry, facilitating partnerships that accelerate research and development in Cell and Gene Therapy.

Icon

Networking Opportunities

Connect with leading researchers, industry experts, and decision-makers to explore collaborations, funding opportunities, and strategic partnerships.

Icon

Cutting-edge Research

Gain insights into the latest discoveries and advancements in Cell and Gene Therapy through keynote presentations, panel discussions, and interactive sessions.

Icon

Industry Impact

Learn how academic research can translate into practical applications that impact the industry, paving the way for transformative therapies and treatments.

// SCIENTIFIC SESSION

Key Symposia and Sessions

  • Current Landscape and Future Directions of Cell and Gene Therapy Research
  • Advances in Gene Editing Technologies for Cellular Engineering
  • Stem Cell-Based Therapies: From Bench to Bedside
  • Emerging Gene Therapies for Monogenic Disorders
  • Immunotherapy Approaches: CAR-T Cells and Beyond
  • Cellular Reprogramming and Regenerative Medicine
  • Gene Therapy for Neurodegenerative Diseases: Challenges and Progress
  • Non-Viral Gene Delivery Strategies: Enhancing Safety and Efficiency
  • Clinical Applications of CRISPR-Cas9: Opportunities and Considerations
  • Gene Editing for Hematological Disorders: Promising Results and Ongoing Trials
  • Gene Therapy for Rare Diseases: Navigating Orphan Drug Development
  • Therapeutic Applications of RNA-Based Therapies
  • Gene Therapy Approaches for Cancer Treatment

  • CRISPR-Cas9 Advancements: Latest Developments and Applications
  • Beyond CRISPR: Emerging Gene Editing Technologies and Techniques
  • Gene Therapy Target Identification: From Disease Mechanisms to Therapeutic Targets
  • Precision Genome Editing: Strategies for Specific Gene Modifications
  • Editing Non-Coding DNA: Implications for Gene Regulation and Disease Treatment
  • Gene Editing in Stem Cells: Toward Personalized Cell Therapies
  • Gene Delivery Methods: Ensuring Efficient and Safe Editing in Clinical Settings
  • Genetic Disease Models: Translating Findings from Bench to Bedside
  • Immune System Engineering: Enhancing Cell Therapies through Gene Editing

  • Manufacturing Strategies for Global Accessibility of Cell and Gene Therapies
  • Process Development and Scale-Up: Challenges and Solutions
  • Quality Control and Assurance in Cell and Gene Therapy Manufacturing
  • Automation and Robotics in Bioprocessing
  • Gene Therapy Vector Production: Advancements and Innovations
  • Ensuring Supply Chain Efficiency for Cell and Gene Therapies
  • Addressing Logistics Challenges in Cell and Gene Therapy Distribution
  • Patient-Specific Manufacturing Approaches: Personalized Medicine at Scale
  • GMP Compliance and Regulatory Considerations in Manufacturing
  • Developing Next-Generation Manufacturing Technologies
  • Contract Manufacturing and Outsourcing Strategies
  • Cost Optimization and Affordability in Cell and Gene Therapy Production
  • Global Collaboration for Streamlining Manufacturing Processes
  • Cell and Gene Therapy Manufacturing Success Stories from Different Regions

  • Navigating the Evolving Regulatory Landscape for Cell and Gene Therapies
  • Regulatory Pathways for Accelerated Approvals and Expedited Reviews
  • Addressing Safety and Efficacy Requirements in Regulatory Submissions
  • Risk Management and Pharmacovigilance in Cell and Gene Therapy Trials
  • Reimbursement Models for Advanced Therapies: Challenges and Opportunities
  • Pricing Strategies and Value-Based Pricing for Cell and Gene Therapies
  • Market Entry and Commercialization Planning for Cell and Gene Therapies
  • Market Analysis and Forecasting for Advanced Therapy Products
  • Building Successful Partnerships with Healthcare Providers and Payers
  • Intellectual Property and Patent Strategies in Commercialization
  • Case Studies: From Clinical Trials to Market Success

Media Partner

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network for the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.

Testimonials

// Gallery

2024 Conference Highlights

Who will Attend Cell and Gene Therapy Summit?

Department

  • Manufacturing
  • Product Development
  • Quality
  • Value & Market Access
  • Therapy Administration
  • Research & Development
  • Regulatory Affairs
  • Vector Systems
  • Engineering
  • Laboratory
  • Science
  • Information Technology
  • Validation
  • Training
  • Clinical
  • Patient Advocacy

Job Function

  • Scientist
  • Executive and Mid-Level Management
  • Project Management
  • Technical Services
  • Supply Chain
  • Manufacturing
  • Application
  • Risk Management
  • Patient Monitoring
  • Customer Engagement
  • Marketing and Sales
  • Clinical Strategy Pharmacist
  • Product Communications
  • Clinical Research
  • Post Doc, PhD Student
// Patners

Past Exhibitors

Exhibitor
Exhibitor
Exhibitor
Exhibitor
Envoya Inc Exhibitor
Chemometec
zerogravityskin


For regular updates bookmark Global Cell & Gene Therapy Summit website